Subtype
Malignant Colorectal Neoplasm
CI-CAN-00005874Explore in graph →
1,565 active trials21 approved drugs382 evidence items
- NCIt
- C4978
- DOID
- 9256
- Other
- 1 more code
Loading cancer entity…
Subtype
CI-CAN-00005874Explore in graph →
Clinical trials
7,294 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (722)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00182130 | Quality Initiative in Rectal Cancer (QIRC) Trial | unknown | N/A | 691 | Hamilton Health Sciences CorporationOTHER | 0 | Sep 16, 2005 | clinicaltrials |
| NCT00173277 | Screening for CRC Using a Mixed Strategy of Sigmoidoscopy and Colonoscopy in Average-Risk Population According to Age | unknown | — | 2,500 | National Taiwan University HospitalOTHER | 1 | Sep 15, 2005 | clinicaltrials |
| NCT00154713 | Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment | unknown | Phase 1 / Phase 2 | 37 | National Taiwan University HospitalOTHER | 1 | Sep 12, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Sep 16, 2005source: clinicaltrials